{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:43:16Z","timestamp":1792593796741,"version":"4.5.0"},"reference-count":33,"publisher":"MyJove Corporation","issue":"224","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69294","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:01:25Z","timestamp":1760742085000},"source":"Crossref","is-referenced-by-count":0,"title":["Long Non-Coding RNA PVT1 Enhances Glycolysis in Thyroid Carcinoma by Stabilizing HIF-1α and Activating Glycolytic Gene Transcription"],"prefix":"10.3791","author":[{"given":"Yingrui","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"10387","key":"ref1","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","type":"journal-article","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","unstructured":"Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., Haymart, M. R. Thyroid cancer. Lancet. 401 (10387), 1531-1544 (2023).","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fendo.2020.00082","type":"journal-article","article-title":"New Therapies for Advanced Thyroid Cancer","volume":"11","author":"Laha","year":"2020","unstructured":"Laha, D., Nilubol, N., Boufraqech, M. New Therapies for Advanced Thyroid Cancer. Front Endocrinol. 11, 82 (2020).","journal-title":"Front Endocrinol"},{"issue":"10061","key":"ref3","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","type":"journal-article","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","unstructured":"Cabanillas, M. E., McFadden, D. G., Durante, C. Thyroid cancer. Lancet. 388 (10061), 2783-2795 (2016).","journal-title":"Lancet"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","type":"journal-article","article-title":"Evolving Understanding of the Epidemiology of Thyroid Cancer","volume":"48","author":"Seib","year":"2019","unstructured":"Seib, C. D., Sosa, J. A. Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinol Metab Clin North Am. 48 (1), 23-35 (2019).","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","type":"journal-article","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","unstructured":"Bridges, M. C., Daulagala, A. C., Kourtidis, A. LNCcation: lncRNA localization and function. J Cell Biol. 220 (2), e202009045 (2021).","journal-title":"J Cell Biol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","type":"journal-article","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","unstructured":"Tan, Y. T. et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 41 (2), 109-120 (2021).","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","type":"journal-article","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","unstructured":"Herman, A. B., Tsitsipatis, D., Gorospe, M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 82 (12), 2252-2266 (2022).","journal-title":"Mol Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"154675","DOI":"10.1016\/j.prp.2023.154675","type":"journal-article","article-title":"LncRNA PVT1: as a therapeutic target for breast cancer","volume":"248","author":"Baljon","year":"2023","unstructured":"Baljon, K. J. et al. LncRNA PVT1: as a therapeutic target for breast cancer. Pathol Res Pract. 248, 154675 (2023).","journal-title":"Pathol Res Pract"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.2147\/DDDT.S332847","type":"journal-article","article-title":"Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1\/miR-214-3p\/GPX4","volume":"15","author":"He","year":"2021","unstructured":"He, G. N. et al. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1\/miR-214-3p\/GPX4. Drug Des Dev Ther. 15, 3965-3978 (2021).","journal-title":"Drug Des Dev Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/OTT.S190239","type":"journal-article","article-title":"LncRNA PVT1 promotes proliferation, invasion and epithelial-mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p","volume":"12","author":"Ren","year":"2019","unstructured":"Ren, Y. et al. LncRNA PVT1 promotes proliferation, invasion and epithelial-mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p. OncoTargets Ther. 12, 2563-2575 (2019).","journal-title":"OncoTargets Ther"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","type":"journal-article","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells","volume":"41","author":"Liberti","year":"2016","unstructured":"Liberti, M. V., Locasale, J. W. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 41 (3), 211-218 (2016).","journal-title":"Trends Biochem Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","type":"journal-article","article-title":"Tumor hypoxia: From basic knowledge to therapeutic implications","volume":"88","author":"Liao","year":"2023","unstructured":"Liao, C., Liu, X., Zhang, C., Zhang, Q. Tumor hypoxia: From basic knowledge to therapeutic implications. Semin Cancer Biol. 88, 172-186 (2023).","journal-title":"Semin Cancer Biol"},{"issue":"Suppl 1","key":"ref13","doi-asserted-by":"crossref","first-page":"i99","DOI":"10.1093\/jrr\/rrw012","type":"journal-article","article-title":"Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance","volume":"57","author":"Harada","year":"2016","unstructured":"Harada, H. Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance. J Radiat Res. 57 (Suppl 1), i99-i105 (2016).","journal-title":"J Radiat Res"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s13258-023-01368-8","type":"journal-article","article-title":"LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p","volume":"45","author":"Qu","year":"2023","unstructured":"Qu, H. et al. LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p. Genes Genom. 45 (5), 581-592 (2023).","journal-title":"Genes Genom"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.7150\/jca.37959","type":"journal-article","article-title":"Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating MiR-519d-3p and HIF-1A","volume":"11","author":"Sun","year":"2020","unstructured":"Sun, J., Zhang, P., Yin, T., Zhang, F., Wang, W. Upregulation of LncRNA PVT1 Facilitates Pancreatic Ductal Adenocarcinoma Cell Progression and Glycolysis by Regulating MiR-519d-3p and HIF-1A. J Cancer. 11 (9), 2572-2579 (2020).","journal-title":"J Cancer"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2017.06.024","type":"journal-article","article-title":"Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497\/HK2 axis in osteosarcoma","volume":"490","author":"Song","year":"2017","unstructured":"Song, J. et al. Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497\/HK2 axis in osteosarcoma. Biochem Bioph Res Co. 490 (2), 217-224 (2017).","journal-title":"Biochem Bioph Res Co"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41418-019-0381-y","type":"journal-article","article-title":"The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1\u03b1","volume":"27","author":"Wang","year":"2020","unstructured":"Wang, Y. et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1\u03b1. Cell Death Differ. 27 (2), 695-710 (2020).","journal-title":"Cell Death Differ"},{"issue":"2","key":"ref18","first-page":"193","type":"journal-article","article-title":"Long non-coding RNA UPK1A-AS1 promotes glycolysis in hepatocellular carcinoma cells via stabilization of HIF-1\u03b1","volume":"41","author":"Zhang","year":"2021","unstructured":"Zhang, D., Zou, X., Song, Y., Wu, D. Long non-coding RNA UPK1A-AS1 promotes glycolysis in hepatocellular carcinoma cells via stabilization of HIF-1\u03b1. J South Med Uni. 41 (2), 193-199 (2021).","journal-title":"J South Med Uni"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","type":"journal-article","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","unstructured":"Livak, K. J., Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 25 (4), 402-408 (2001).","journal-title":"Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"959208","DOI":"10.3389\/fonc.2022.959208","type":"journal-article","article-title":"Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer","volume":"12","author":"Yao","year":"2022","unstructured":"Yao, W. et al. Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer. Front Oncol. 12, 959208 (2022).","journal-title":"Front Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"102312","DOI":"10.1016\/j.redox.2022.102312","type":"journal-article","article-title":"Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer","volume":"52","author":"Lin","year":"2022","unstructured":"Lin, Z. et al. Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biol. 52, 102312 (2022).","journal-title":"Redox Biol"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","type":"journal-article","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","unstructured":"Filetti, S. et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 30 (12), 1856-1883 (2019).","journal-title":"Ann Oncol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.3390\/ijms23094631","type":"journal-article","article-title":"Recent Advances in Thyroid Cancer Research","volume":"23","author":"Grimm","year":"2022","unstructured":"Grimm, D. Recent Advances in Thyroid Cancer Research. Int J Mol Sci. 23 (9), 4631 (2022).","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","type":"journal-article","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","unstructured":"Vaupel, P., Multhoff, G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 599 (6), 1745-1757 (2021).","journal-title":"J Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"100787","DOI":"10.1016\/j.drup.2021.100787","type":"journal-article","article-title":"Hypoxia as a driver of resistance to immunotherapy","volume":"59","author":"Kopecka","year":"2021","unstructured":"Kopecka, J. et al. Hypoxia as a driver of resistance to immunotherapy. Drug Resist Update. 59, 100787 (2021).","journal-title":"Drug Resist Update"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fonc.2020.00998","type":"journal-article","article-title":"Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p\/UCK2","volume":"10","author":"Zhang","year":"2020","unstructured":"Zhang, Q. et al. Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p\/UCK2. Front Oncol. 10, 998 (2020).","journal-title":"Front Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","type":"journal-article","article-title":"Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer","volume":"37","author":"Yang","year":"2021","unstructured":"Yang, H. et al. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J Adv Res. 37, 91-106 (2021).","journal-title":"J Adv Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2021.06.002","type":"journal-article","article-title":"lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability","volume":"566","author":"Ma","year":"2021","unstructured":"Ma, Y. et al. lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability. Biochem Bioph Res Co. 566, 101-107 (2021).","journal-title":"Biochem Bioph Res Co"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jmcb\/mjab042","type":"journal-article","article-title":"A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1\u03b1 in pancreatic cancer","volume":"13","author":"Zhu","year":"2021","unstructured":"Zhu, Y. et al. A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1\u03b1 in pancreatic cancer. J Mol Cell Biol. 13 (9), 676-689 (2021).","journal-title":"J Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2022.10.010","type":"journal-article","article-title":"PVT1\/miR-145-5p\/HK2 modulates vascular smooth muscle cells phenotype switch via glycolysis: The new perspective on the spiral artery remodeling","volume":"130","author":"Wu","year":"2022","unstructured":"Wu, M. et al. PVT1\/miR-145-5p\/HK2 modulates vascular smooth muscle cells phenotype switch via glycolysis: The new perspective on the spiral artery remodeling. Placenta. 130, 25-33 (2022).","journal-title":"Placenta"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/cells9102278","type":"journal-article","article-title":"mTOR Signaling in Metabolism and Cancer","volume":"9","author":"Huang","year":"2020","unstructured":"Huang, S. mTOR Signaling in Metabolism and Cancer. Cells. 9 (10), 2278 (2020).","journal-title":"Cells"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"E1435","DOI":"10.1210\/jc.2010-2373","type":"journal-article","article-title":"Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach","volume":"96","author":"Riesco-Eizaguirre","year":"2011","unstructured":"Riesco-Eizaguirre, G. et al. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach. J Clin Endocrinol Metab. 96 (9), E1435-E1443 (2011).","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"101013","DOI":"10.1016\/j.drup.2023.101013","type":"journal-article","article-title":"Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","unstructured":"Shen, H. et al. Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resist Updat. 72, 101013 (2024).","journal-title":"Drug Resist Updat"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69294\/long-non-coding-rna-pvt1-enhances-glycolysis-thyroid-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:22Z","timestamp":1792592422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69294\/long-non-coding-rna-pvt1-enhances-glycolysis-thyroid-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":33,"journal-issue":{"issue":"224","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/69294","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}